https://www.selleckchem.com/pr....oducts/sch-527123.ht
Our findings suggest that anti-VEGF strategies may prove useful as possible therapies for limiting the progression of early-stage DR. VEGF inhibition through aflibercept treatment decreased leukocyte recruitment and aggregation, perfusion blockage, retinal hypoperfusion, and hyperpermeability in mice with diabetes and ultimately attenuated pericyte loss. Our findings suggest that anti-VEGF strategies may prove useful as possible therapies for limiting the progression of early-stage DR. To collate the genes experimentally modulated in
Like
Comment
Share
